Option FanaticOptions, stock, futures, and system trading, backtesting, money management, and much more!

TROW Stock Study (10-18-25)

I recently did a stock study on T. Rowe Price Group, Inc. (TROW, $103.15). Previous study is here.

M* writes:

     > T. Rowe Price provides asset management services for individual
     > and institutional investors. It offers a broad range of no-load
     > US and international stock, hybrid, bond, and money market funds…
     > Approximately two-thirds of managed assets are held in retirement-
     > based accounts, which provides T. Rowe Price with a somewhat
     > stickier client base than most of its peers. The firm also
     > manages private accounts, provides retirement planning advice,
     > and offers discount brokerage and trust services. The company
     > is primarily a US-based asset manager, deriving less than 10%
     > of its AUM from overseas.

Over the last decade, this medium-size company has grown sales and EPS at annualized rates of 6.5% and 7.6%, respectively. Lines are up, straight, and parallel except for sales dips in ’22 (large) and ’23 and EPS dip in ’22. Five- (10-) year EPS R^2 is 0.19 (0.46) and Value Line (VL) gives an Earnings Predictability rating of 90.

Over the last decade, PTPM leads peer and industry averages despite falling from 47.7% (’15) to 39.7% (’24) with a last-5-year mean of 42.5%. ROE also leads peer and industry averages despite falling from 24.8% (’15) to 19.9% (’24) with a last-5-year mean of 24.7%. The company has no long-term debt and is therefore lower than peers and the industry on Debt-to-Capital with a last-5-year mean of 2.8% (rentals).

Quick Ratio is 10.95 with Interest Coverage N/A (consistent with no long-term debt) per M* who assigns a “Narrow” Economic Moat, gives an “Exemplary” rating for Capital Allocation, and offers an A grade for Financial Health. VL rates the company A+ for Financial Strength.

With regard to sales growth:

My 2.0% forecast is below the range.

With regard to EPS growth:

My 0.5% per year forecast is toward bottom of the long-term-estimate range (mean of seven: 3.5%). My initial value is 2025 Q2 EPS of $8.95/share (annualized) instead of ’24 EPS of $9.15.

My Forecast High P/E is 13.0. Over the last 10 years, high P/E decreases from 18.8 (’15) to 13.7 (’24) with a last 5-year mean of 15.9 (29.7 outlier in ’22 excluded) and last 5-year-mean average P/E of 13.5. I am below the range.

My Forecast Low P/E is 8.0. Over the last 10 years, low P/E decreases from 14.2 (’15) to 11.0 (’24) with a last-5-year mean of 11.1. I am forecasting below the range and current P/E (14.8).

My Low Stock Price Forecast (LSPF) of $71.60 is default based on initial value given above. This is 30.6% (8.0%) less than the previous close (52-week low).

Over the past decade, Payout Ratio ranges from 32.9% in ’21 to 71.6% in ’22 with a last-5-year mean of 51.5%. I am forecasting below the range at 32.0%.

These inputs land TROW in the HOLD zone with a U/D ratio of 0.5. Total Annualized Return (TAR) is 5.4%.

PAR (using Forecast Average—not High—P/E) is less than the current risk-free rate (T-bills) at 1.7%. If a healthy margin of safety (MOS) anchors this study, then I can proceed based on TAR instead (still less than I seek in a medium-size company).

To assess MOS, I compare my inputs with those of Member Sentiment (MS). Based on 78 studies done in the past 90 days (my study and 27 other outliers excluded), averages (lower of mean/median) for projected sales growth, projected EPS growth, Forecast High P/E, Forecast Low P/E, and Payout Ratio are 5.2%, 5.8%, 15.0, 10.7, and 47.4%. I am lower across the board. VL projects a future average annual P/E of 13.0, which is higher than MS (12.9) and higher than mine (10.5).

MS high / low EPS are $12.01 / $8.79 versus my $9.18 / $8.95 (per share). My high EPS is less due to a lower growth rate. VL’s high EPS soars above both at $13.00.

MS LSPF of $89.30 implies a Forecast Low P/E of 10.2: less than the above-stated 10.7. MS LSPF is 5.1% less than the default $8.79/share * 10.7 = $94.05 resulting in more conservative zoning. MS LSPF is still 24.7% greater than mine.

I believe MOS is robust in this study because my inputs are near or below respective analyst/historical ranges and MS averages. MS TAR of 14.8% is 9.4% per year greater than mine.

With regard to valuation, PEG is 5.7 and 22.9 (fractional growth rate) per Zacks and my projected P/E, respectively: significantly overvalued (also by M* at 9.4). Relative Value [(current P/E) / 5-year-mean average P/E] is cheap at 0.85.

Per U/D, TROW is a BUY under $83/share. BI TAR criterion is met ~ 119.3 / ((12.37 / 100 ) +1 ) ^ 5 = $66.50 given forecast high price ~$119.

A 90-day free trial to BetterInvestingĀ® may be secured here (also see link under “Pages” section at top right of this page).